13 M$ de plus pour Aleva Neurotherapeutics

13 M$ de plus pour Aleva Neurotherapeutics

Aleva Neurotherapeutics, an EPFL spinoff developing implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s disease and Essential Tremor, today announced that it has raised USD 13 million in a Series D financing round. The round was led by Forrestal Capital, a fund with specific experience in neurological devices. Aleva’s existing investors have also participated in the round.

MORE

Leave a reply